Alzheimer’s Prognostic Tech from Diadem Gets Licensing Agreement With Quest
Diadem formed a strategic collaboration with Quest Diagnostics to improve access to blood tests for evaluating the risk of Alzheimer’s.
Read MorePosted by Andy Lundin | Oct 30, 2023 | Company News, Dementias & Alzheimer’s |
Diadem formed a strategic collaboration with Quest Diagnostics to improve access to blood tests for evaluating the risk of Alzheimer’s.
Read MorePosted by Andy Lundin | Oct 27, 2023 | Diagnostic Technologies |
Cordance Medical’s device, NeuroAccess, has been granted Breakthrough Device Designation by the U.S. Food and Drug Administration (FDA).
Read MorePosted by Andy Lundin | Oct 26, 2023 | Cardiovascular |
Mindray introduced new cardiac biomarkers aimed at diversifying its portfolio for cardiovascular disease diagnosis and management.
Read MorePosted by Andy Lundin | Oct 26, 2023 | Cancer, Company News |
QIAGEN and Myriad Genetics announced a new master collaboration agreement to develop companion diagnostic tests in the field of cancer.
Read MorePosted by Andy Lundin | Oct 24, 2023 | Digital Pathology |
Proscia earned ISO 27001 certification, demonstrating the company’s compliance with a well-known information security management standard.
Read More